Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF4 antibody

TNFRSF4 Reactivity: Rat FACS, IP, IHC (fro) Host: Mouse Monoclonal OX-40 unconjugated
Catalog No. ABIN2478394
  • Target See all TNFRSF4 Antibodies
    TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
    Reactivity
    • 73
    • 43
    • 31
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Rat
    Host
    • 63
    • 32
    • 7
    • 2
    Mouse
    Clonality
    • 59
    • 44
    • 1
    Monoclonal
    Conjugate
    • 55
    • 10
    • 8
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This TNFRSF4 antibody is un-conjugated
    Application
    • 55
    • 40
    • 32
    • 15
    • 14
    • 13
    • 11
    • 10
    • 10
    • 6
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Characteristics
    Purified IgG
    Purification
    Purified
    Immunogen
    Phytohemagglutinin (PHA) activated Rat Lymph Node Cells
    Clone
    OX-40
    Isotype
    IgG2b
    Top Product
    Discover our top product TNFRSF4 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.0 mg/mL
  • Cousins, Graham, Tooze, Carter, Miller, Powrie, Macpherson, Butcher: "Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene." in: Gastroenterology, Vol. 131, Issue 5, pp. 1475-85, (2006) (PubMed).

  • Target
    TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
    Alternative Name
    CD134 (TNFRSF4 Products)
    Background
    Synonyms: OX40
    Gene ID
    25572
    UniProt
    P15725
    Pathways
    Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
You are here:
Support